Clinical Study

Negative Predictive Value of Human Papillomavirus Testing: Implications for Anal Cancer Screening in People Living with HIV/AIDS

Table 1

Clinicopathological characteristics for Cobas-negative individuals by HRA-guided biopsy result.

CharacteristicsTotal (n = 156)HRA-guided biopsy value
Benign (n = 56)LSIL (n = 82)HSIL (n = 18)

Age (mean, range, yrs.)49 (23–71)48 (23–69)49 (26–70)49 (25–71)0.73

Gender and sexual behavior
 MSM129 (83)46 (82)67 (82)16 (89)0.10
 HM8 (5)6 (11)2 (2)
 Female19 (12)4 (7)13 (16)2 (11)

Receptive anal sex
 Yes145 (93)48 (86)79 (96)18 (100)0.03
 No11 (7)8 (14)3 (4)

CD4+ T-cell count (cells/ml)
 <50032 (21)10 (19)16 (20)6 (35)0.32
 ≥500118 (79)43 (81)64 (80)11 (65)
 Unknown6321

HIV-1 viral load (copies/ml)
 <100140 (90)47 (84)76 (93)17 (94)0.20
 ≥10016 (10)9 (16)6 (7)1 (6)

Race/ethnicity
 Caucasian33 (26)6 (14)22 (34)5 (31)0.10
 African American27 (22)10 (23)15 (23)2 (13)
 Hispanic47 (38)20 (45)23 (35)4 (25)
 Other18 (14)8 (18)5 (8)5 (31)
 Unknown3112172

Smoking history
 Current35 (22)15 (27)15 (18)5 (28)0.42
 Former46 (30)14 (25)29 (35)3 (17)
 Never75 (48)27 (48)38 (47)10 (55)

Anorectal cytology at the time of HRA
 Unsatisfactory2 (1)1 (2)1 (5)0.02
 Benign75 (48)35 (62)37 (45)3 (17)
 ASCUS62 (40)18 (32)33 (40)11 (61)
 LSIL13 (8)1 (2)10 (13)2 (11)
 HSIL, ASC-H4 (3)1 (2)2 (2)1 (5)

MSM: men who have sex with men; ∗∗HM: heterosexual men.